<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-08-12" version="236">
<accession>Q16665</accession>
<accession>C0LZJ3</accession>
<accession>Q53XP6</accession>
<accession>Q96PT9</accession>
<accession>Q9UPB1</accession>
<name>HIF1A_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="61">Hypoxia-inducible factor 1-alpha</fullName>
<shortName evidence="61">HIF-1-alpha</shortName>
<shortName evidence="61">HIF1-alpha</shortName>
</recommendedName>
<alternativeName>
<fullName>ARNT-interacting protein</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="62">Basic-helix-loop-helix-PAS protein MOP1</fullName>
</alternativeName>
<alternativeName>
<fullName>Class E basic helix-loop-helix protein 78</fullName>
<shortName>bHLHe78</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="62">Member of PAS protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>PAS domain-containing protein 8</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="61">HIF1A</name>
<name type="synonym">BHLHE78</name>
<name type="synonym" evidence="62">MOP1</name>
<name type="synonym">PASD8</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="5510" last="5514">
<title>Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.</title>
<authorList>
<person name="Wang G.L."/>
<person name="Jiang B.-H."/>
<person name="Rue E.A."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="7539918"/>
<dbReference type="DOI" id="10.1073/pnas.92.12.5510"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 166-170; 259-289 AND 771-781</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="8581" last="8593">
<title>Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway.</title>
<authorList>
<person name="Hogenesch J.B."/>
<person name="Chan W.K."/>
<person name="Jackiw V.H."/>
<person name="Brown R.C."/>
<person name="Gu Y.-Z."/>
<person name="Pray-Grant M."/>
<person name="Perdew G.H."/>
<person name="Bradfield C.A."/>
</authorList>
<dbReference type="PubMed" id="9079689"/>
<dbReference type="DOI" id="10.1074/jbc.272.13.8581"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Genomics" volume="52" first="159" last="165">
<title>The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation.</title>
<authorList>
<person name="Iyer N.V."/>
<person name="Leung S.W."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="9782081"/>
<dbReference type="DOI" id="10.1006/geno.1998.5416"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Hum. Immunol." volume="69" first="421" last="425">
<title>Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytes.</title>
<authorList>
<person name="Lukashev D."/>
<person name="Sitkovsky M."/>
</authorList>
<dbReference type="PubMed" id="18638657"/>
<dbReference type="DOI" id="10.1016/j.humimm.2008.05.004"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="5">
<citation type="submission" date="1999-11" db="EMBL/GenBank/DDBJ databases">
<title>HIF1a sequence in the Quechua, a high altitude population.</title>
<authorList>
<person name="Rupert J.L."/>
<person name="Hochachka P.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2000-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Sun B."/>
<person name="Zhao H.R."/>
<person name="Yu R.T."/>
<person name="Ni M.S.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Glial tumor</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2001-10" db="EMBL/GenBank/DDBJ databases">
<title>Hypoxia-inducible factor-1 alpha variant isolated from human liver tissue.</title>
<authorList>
<person name="Tanaka S."/>
<person name="Sugimachi K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Nature" volume="421" first="601" last="607">
<title>The DNA sequence and analysis of human chromosome 14.</title>
<authorList>
<person name="Heilig R."/>
<person name="Eckenberg R."/>
<person name="Petit J.-L."/>
<person name="Fonknechten N."/>
<person name="Da Silva C."/>
<person name="Cattolico L."/>
<person name="Levy M."/>
<person name="Barbe V."/>
<person name="De Berardinis V."/>
<person name="Ureta-Vidal A."/>
<person name="Pelletier E."/>
<person name="Vico V."/>
<person name="Anthouard V."/>
<person name="Rowen L."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Sun H."/>
<person name="Du H."/>
<person name="Pepin K."/>
<person name="Artiguenave F."/>
<person name="Robert C."/>
<person name="Cruaud C."/>
<person name="Bruels T."/>
<person name="Jaillon O."/>
<person name="Friedlander L."/>
<person name="Samson G."/>
<person name="Brottier P."/>
<person name="Cure S."/>
<person name="Segurens B."/>
<person name="Aniere F."/>
<person name="Samain S."/>
<person name="Crespeau H."/>
<person name="Abbasi N."/>
<person name="Aiach N."/>
<person name="Boscus D."/>
<person name="Dickhoff R."/>
<person name="Dors M."/>
<person name="Dubois I."/>
<person name="Friedman C."/>
<person name="Gouyvenoux M."/>
<person name="James R."/>
<person name="Madan A."/>
<person name="Mairey-Estrada B."/>
<person name="Mangenot S."/>
<person name="Martins N."/>
<person name="Menard M."/>
<person name="Oztas S."/>
<person name="Ratcliffe A."/>
<person name="Shaffer T."/>
<person name="Trask B."/>
<person name="Vacherie B."/>
<person name="Bellemere C."/>
<person name="Belser C."/>
<person name="Besnard-Gonnet M."/>
<person name="Bartol-Mavel D."/>
<person name="Boutard M."/>
<person name="Briez-Silla S."/>
<person name="Combette S."/>
<person name="Dufosse-Laurent V."/>
<person name="Ferron C."/>
<person name="Lechaplais C."/>
<person name="Louesse C."/>
<person name="Muselet D."/>
<person name="Magdelenat G."/>
<person name="Pateau E."/>
<person name="Petit E."/>
<person name="Sirvain-Trukniewicz P."/>
<person name="Trybou A."/>
<person name="Vega-Czarny N."/>
<person name="Bataille E."/>
<person name="Bluet E."/>
<person name="Bordelais I."/>
<person name="Dubois M."/>
<person name="Dumont C."/>
<person name="Guerin T."/>
<person name="Haffray S."/>
<person name="Hammadi R."/>
<person name="Muanga J."/>
<person name="Pellouin V."/>
<person name="Robert D."/>
<person name="Wunderle E."/>
<person name="Gauguet G."/>
<person name="Roy A."/>
<person name="Sainte-Marthe L."/>
<person name="Verdier J."/>
<person name="Verdier-Discala C."/>
<person name="Hillier L.W."/>
<person name="Fulton L."/>
<person name="McPherson J."/>
<person name="Matsuda F."/>
<person name="Wilson R."/>
<person name="Scarpelli C."/>
<person name="Gyapay G."/>
<person name="Wincker P."/>
<person name="Saurin W."/>
<person name="Quetier F."/>
<person name="Waterston R."/>
<person name="Hood L."/>
<person name="Weissenbach J."/>
</authorList>
<dbReference type="PubMed" id="12508121"/>
<dbReference type="DOI" id="10.1038/nature01348"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Choriocarcinoma</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="12969" last="12973">
<title>An essential role for p300/CBP in the cellular response to hypoxia.</title>
<authorList>
<person name="Arany Z."/>
<person name="Huang L.E."/>
<person name="Eckner R."/>
<person name="Bhattacharya S."/>
<person name="Jiang C."/>
<person name="Goldberg M.A."/>
<person name="Bunn H.F."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="8917528"/>
<dbReference type="DOI" id="10.1073/pnas.93.23.12969"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH EP300 AND CREBBP</scope>
<scope>INTERACTION WITH EP300</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="19253" last="19260">
<title>Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.</title>
<authorList>
<person name="Jiang B.H."/>
<person name="Zheng J.Z."/>
<person name="Leung S.W."/>
<person name="Roe R."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="9235919"/>
<dbReference type="DOI" id="10.1074/jbc.272.31.19253"/>
</citation>
<scope>TRANSACTIVATION DOMAINS NTAD AND CTAD</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="6573" last="6586">
<title>Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.</title>
<authorList>
<person name="Kallio P.J."/>
<person name="Okamoto K."/>
<person name="O'Brien S."/>
<person name="Carrero P."/>
<person name="Makino Y."/>
<person name="Tanaka H."/>
<person name="Poellinger L."/>
</authorList>
<dbReference type="PubMed" id="9822602"/>
<dbReference type="DOI" id="10.1093/emboj/17.22.6573"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-719</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="7987" last="7992">
<title>Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.</title>
<authorList>
<person name="Huang L.E."/>
<person name="Gu J."/>
<person name="Schau M."/>
<person name="Bunn H.F."/>
</authorList>
<dbReference type="PubMed" id="9653127"/>
<dbReference type="DOI" id="10.1073/pnas.95.14.7987"/>
</citation>
<scope>OXYGEN-DEPENDENT DEGRADATION DOMAIN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="1905" last="1914">
<title>Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.</title>
<authorList>
<person name="Ema M."/>
<person name="Hirota K."/>
<person name="Mimura J."/>
<person name="Abe H."/>
<person name="Yodoi J."/>
<person name="Sogawa K."/>
<person name="Poellinger L."/>
<person name="Fujii-Kuriyama Y."/>
</authorList>
<dbReference type="PubMed" id="10202154"/>
<dbReference type="DOI" id="10.1093/emboj/18.7.1905"/>
</citation>
<scope>TRANSACTIVATION DOMAINS NTAD AND CTAD</scope>
<scope>INTERACTION WITH APEX</scope>
<scope>MUTAGENESIS OF CYS-800</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="64" last="75">
<title>Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.</title>
<authorList>
<person name="Bhattacharya S."/>
<person name="Michels C.M."/>
<person name="Leung M.K."/>
<person name="Arany Z.P."/>
<person name="Kung A.L."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="9887100"/>
<dbReference type="DOI" id="10.1101/gad.13.1.64"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>INTERACTION WITH EP300</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="276" first="355" last="361">
<title>Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity.</title>
<authorList>
<person name="Aso T."/>
<person name="Yamazaki K."/>
<person name="Aigaki T."/>
<person name="Kitajima S."/>
</authorList>
<dbReference type="PubMed" id="11006129"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3451"/>
</citation>
<scope>INTERACTION WITH VHL</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="EMBO J." volume="19" first="4298" last="4309">
<title>Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.</title>
<authorList>
<person name="Tanimoto K."/>
<person name="Makino Y."/>
<person name="Pereira T."/>
<person name="Poellinger L."/>
</authorList>
<dbReference type="PubMed" id="10944113"/>
<dbReference type="DOI" id="10.1093/emboj/19.16.4298"/>
</citation>
<scope>INTERACTION WITH VHL AND ARNT</scope>
<scope>MUTAGENESIS OF LYS-532; LYS-538; LYS-547 AND LYS-719</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="402" last="415">
<title>Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.</title>
<authorList>
<person name="Carrero P."/>
<person name="Okamoto K."/>
<person name="Coumailleau P."/>
<person name="O'Brien S."/>
<person name="Tanaka H."/>
<person name="Poellinger L."/>
</authorList>
<dbReference type="PubMed" id="10594042"/>
<dbReference type="DOI" id="10.1128/mcb.20.1.402-415.2000"/>
</citation>
<scope>INTERACTION WITH NCOA1; NCOA2 AND APEX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="4748" last="4753">
<title>Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations.</title>
<authorList>
<person name="Sutter C.H."/>
<person name="Laughner E."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="10758161"/>
<dbReference type="DOI" id="10.1073/pnas.080072497"/>
</citation>
<scope>MUTAGENESIS OF SER-551 AND THR-552</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="5197" last="5206">
<title>Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.</title>
<authorList>
<person name="Masson N."/>
<person name="Willam C."/>
<person name="Maxwell P.H."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
</authorList>
<dbReference type="PubMed" id="11566883"/>
<dbReference type="DOI" id="10.1093/emboj/20.18.5197"/>
</citation>
<scope>HYDROXYLATION AT PRO-402 AND PRO-564</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH THE VHLE COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF PRO-394; LEU-397; LEU-400; PRO-402 AND PRO-564</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="FEBS Lett." volume="498" first="62" last="66">
<title>Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7.</title>
<authorList>
<person name="Cho S."/>
<person name="Choi Y.J."/>
<person name="Kim J.M."/>
<person name="Jeong S.T."/>
<person name="Kim J.H."/>
<person name="Kim S.H."/>
<person name="Ryu S.E."/>
</authorList>
<dbReference type="PubMed" id="11389899"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)02499-1"/>
</citation>
<scope>INTERACTION WITH PSMA7</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Science" volume="292" first="468" last="472">
<title>Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.</title>
<authorList>
<person name="Jaakkola P."/>
<person name="Mole D.R."/>
<person name="Tian Y.-M."/>
<person name="Wilson M.I."/>
<person name="Gielbert J."/>
<person name="Gaskell S.J."/>
<person name="von Kriegsheim A."/>
<person name="Hebestreit H.F."/>
<person name="Mukherji M."/>
<person name="Schofield C.J."/>
<person name="Maxwell P.H."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
</authorList>
<dbReference type="PubMed" id="11292861"/>
<dbReference type="DOI" id="10.1126/science.1059796"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>FUNCTION</scope>
<scope>HYDROXYLATION AT PRO-564</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Cell" volume="111" first="709" last="720">
<title>Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.</title>
<authorList>
<person name="Jeong J.-W."/>
<person name="Bae M.-K."/>
<person name="Ahn M.-Y."/>
<person name="Kim S.-H."/>
<person name="Sohn T.-K."/>
<person name="Bae M.-H."/>
<person name="Yoo M.-A."/>
<person name="Song E.-J."/>
<person name="Lee K.-J."/>
<person name="Kim K.-W."/>
</authorList>
<dbReference type="PubMed" id="12464182"/>
<dbReference type="DOI" id="10.1016/s0092-8674(02)01085-1"/>
</citation>
<scope>INTERACTION WITH ARD1A</scope>
<scope>ACETYLATION AT LYS-532</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="1466" last="1471">
<title>FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.</title>
<authorList>
<person name="Lando D."/>
<person name="Peet D.J."/>
<person name="Gorman J.J."/>
<person name="Whelan D.A."/>
<person name="Whitelaw M.L."/>
<person name="Bruick R.K."/>
</authorList>
<dbReference type="PubMed" id="12080085"/>
<dbReference type="DOI" id="10.1101/gad.991402"/>
</citation>
<scope>HYDROXYLATION AT ASN-803</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="13459" last="13464">
<title>Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.</title>
<authorList>
<person name="Ivan M."/>
<person name="Haberberger T."/>
<person name="Gervasi D.C."/>
<person name="Michelson K.S."/>
<person name="Guenzler V."/>
<person name="Kondo K."/>
<person name="Yang H."/>
<person name="Sorokina I."/>
<person name="Conaway R.C."/>
<person name="Conaway J.W."/>
<person name="Kaelin W.G. Jr."/>
</authorList>
<dbReference type="PubMed" id="12351678"/>
<dbReference type="DOI" id="10.1073/pnas.192342099"/>
</citation>
<scope>HYDROXYLATION AT PRO-564</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="FEBS Lett." volume="549" first="105" last="109">
<title>S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity.</title>
<authorList>
<person name="Yasinska I.M."/>
<person name="Sumbayev V.V."/>
</authorList>
<dbReference type="PubMed" id="12914934"/>
<dbReference type="DOI" id="10.1016/s0014-5793(03)00807-x"/>
</citation>
<scope>S-NITROSYLATION AT CYS-800</scope>
<scope>MUTAGENESIS OF CYS-800</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="FEBS Lett." volume="535" first="106" last="112">
<title>HIF-1 alpha protein as a target for S-nitrosation.</title>
<authorList>
<person name="Sumbayev V.V."/>
<person name="Budde A."/>
<person name="Zhou J."/>
<person name="Bruene B."/>
</authorList>
<dbReference type="PubMed" id="12560087"/>
<dbReference type="DOI" id="10.1016/s0014-5793(02)03887-5"/>
</citation>
<scope>S-NITROSYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="Nat. Struct. Biol." volume="10" first="504" last="512">
<title>Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.</title>
<authorList>
<person name="Freedman S.J."/>
<person name="Sun Z.Y."/>
<person name="Kung A.L."/>
<person name="France D.S."/>
<person name="Wagner G."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="12778114"/>
<dbReference type="DOI" id="10.1038/nsb936"/>
</citation>
<scope>INTERACTION WITH EP300</scope>
<scope>MUTAGENESIS OF LEU-795</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="324" first="394" last="400">
<title>Sumoylation increases HIF-1alpha stability and its transcriptional activity.</title>
<authorList>
<person name="Bae S.-H."/>
<person name="Jeong J.-W."/>
<person name="Park J.A."/>
<person name="Kim S.-H."/>
<person name="Bae M.-K."/>
<person name="Choi S.-J."/>
<person name="Kim K.-W."/>
</authorList>
<dbReference type="PubMed" id="15465032"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.09.068"/>
</citation>
<scope>SUMOYLATION AT LYS-391 AND LYS-477</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-389; LYS-391; LYS-392; LYS-442; LYS-460; LYS-477; LYS-532; LYS-538 AND LYS-547</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Mol. Cancer Res." volume="2" first="43" last="52">
<title>Molecular cloning and characterization of the von Hippel-Lindau-like protein.</title>
<authorList>
<person name="Qi H."/>
<person name="Gervais M.L."/>
<person name="Li W."/>
<person name="DeCaprio J.A."/>
<person name="Challis J.R.G."/>
<person name="Ohh M."/>
</authorList>
<dbReference type="PubMed" id="14757845"/>
</citation>
<scope>INTERACTION WITH VHLL</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="EMBO Rep." volume="6" first="373" last="378">
<title>VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha.</title>
<authorList>
<person name="Li Z."/>
<person name="Wang D."/>
<person name="Messing E.M."/>
<person name="Wu G."/>
</authorList>
<dbReference type="PubMed" id="15776016"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400377"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP20</scope>
<scope>INTERACTION WITH USP20</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="6428" last="6432">
<title>Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.</title>
<authorList>
<person name="Arnesen T."/>
<person name="Kong X."/>
<person name="Evjenth R."/>
<person name="Gromyko D."/>
<person name="Varhaug J.E."/>
<person name="Lin Z."/>
<person name="Sang N."/>
<person name="Caro J."/>
<person name="Lillehaug J.R."/>
</authorList>
<dbReference type="PubMed" id="16288748"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.10.036"/>
</citation>
<scope>INTERACTION WITH ARD1A</scope>
<scope>MUTAGENESIS OF LYS-532</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="13612" last="13619">
<title>Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.</title>
<authorList>
<person name="Fath D.M."/>
<person name="Kong X."/>
<person name="Liang D."/>
<person name="Lin Z."/>
<person name="Chou A."/>
<person name="Jiang Y."/>
<person name="Fang J."/>
<person name="Caro J."/>
<person name="Sang N."/>
</authorList>
<dbReference type="PubMed" id="16543236"/>
<dbReference type="DOI" id="10.1074/jbc.m600456200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EP300 IN THE HIF1A/EP300/CREBBP COMPLEX</scope>
<scope>MUTAGENESIS OF ASN-803</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="34056" last="34063">
<title>Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells.</title>
<authorList>
<person name="Choi S.M."/>
<person name="Choi K.-O."/>
<person name="Park Y.K."/>
<person name="Cho H."/>
<person name="Yang E.G."/>
<person name="Park H."/>
</authorList>
<dbReference type="PubMed" id="16973622"/>
<dbReference type="DOI" id="10.1074/jbc.m603913200"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>HYDROXYLATION</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CBPP</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF ASN-803</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="360" first="646" last="652">
<title>SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.</title>
<authorList>
<person name="Berta M.A."/>
<person name="Mazure N."/>
<person name="Hattab M."/>
<person name="Pouyssegur J."/>
<person name="Brahimi-Horn M.C."/>
</authorList>
<dbReference type="PubMed" id="17610843"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.06.103"/>
</citation>
<scope>SUMOYLATION AT LYS-391 AND LYS-477</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-377; LYS-391; LYS-477 AND LYS-532</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Cell" volume="131" first="309" last="323">
<title>RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.</title>
<authorList>
<person name="Carbia-Nagashima A."/>
<person name="Gerez J."/>
<person name="Perez-Castro C."/>
<person name="Paez-Pereda M."/>
<person name="Silberstein S."/>
<person name="Stalla G.K."/>
<person name="Holsboer F."/>
<person name="Arzt E."/>
</authorList>
<dbReference type="PubMed" id="17956732"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.07.044"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>INTERACTION WITH RWDD3</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Mol. Cell" volume="25" first="207" last="217">
<title>RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.</title>
<authorList>
<person name="Liu Y.V."/>
<person name="Baek J.H."/>
<person name="Zhang H."/>
<person name="Diez R."/>
<person name="Cole R.N."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="17244529"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.01.001"/>
</citation>
<scope>INTERACTION WITH RACK1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="604" last="609">
<title>HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.</title>
<authorList>
<person name="Paltoglou S."/>
<person name="Roberts B.J."/>
</authorList>
<dbReference type="PubMed" id="16862177"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209818"/>
</citation>
<scope>UBIQUITINATION AT LYS-532; LYS-538 AND LYS-547</scope>
<scope>INTERACTION WITH VHL</scope>
<scope>MUTAGENESIS OF PRO-402; LYS-532; LYS-538; LYS-547 AND PRO-564</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Arterioscler. Thromb. Vasc. Biol." volume="28" first="1796" last="1802">
<title>Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.</title>
<authorList>
<person name="Kim E.J."/>
<person name="Yoo Y.G."/>
<person name="Yang W.K."/>
<person name="Lim Y.S."/>
<person name="Na T.Y."/>
<person name="Lee I.K."/>
<person name="Lee M.O."/>
</authorList>
<dbReference type="PubMed" id="18658046"/>
<dbReference type="DOI" id="10.1161/atvbaha.108.171546"/>
</citation>
<scope>INTERACTION WITH RORA</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Trends Biochem. Sci." volume="33" first="526" last="534">
<title>HIF-1 regulation: not so easy come, easy go.</title>
<authorList>
<person name="Yee Koh M."/>
<person name="Spivak-Kroizman T.R."/>
<person name="Powis G."/>
</authorList>
<dbReference type="PubMed" id="18809331"/>
<dbReference type="DOI" id="10.1016/j.tibs.2008.08.002"/>
</citation>
<scope>REVIEW ON REGULATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="368" last="377">
<title>Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.</title>
<authorList>
<person name="Nardinocchi L."/>
<person name="Puca R."/>
<person name="Guidolin D."/>
<person name="Belloni A.S."/>
<person name="Bossi G."/>
<person name="Michiels C."/>
<person name="Sacchi A."/>
<person name="Onisto M."/>
<person name="D'Orazi G."/>
</authorList>
<dbReference type="PubMed" id="19046997"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2008.10.013"/>
</citation>
<scope>INDUCTION BY HIPK2</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="185" first="1065" last="1081">
<title>HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport.</title>
<authorList>
<person name="Li Y."/>
<person name="Lim S."/>
<person name="Hoffman D."/>
<person name="Aspenstrom P."/>
<person name="Federoff H.J."/>
<person name="Rempe D.A."/>
</authorList>
<dbReference type="PubMed" id="19528298"/>
<dbReference type="DOI" id="10.1083/jcb.200811033"/>
</citation>
<scope>FUNCTION IN MITOCHONDRIAL TRANSPORT</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="FASEB J." volume="24" first="4443" last="4458">
<title>Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1.</title>
<authorList>
<person name="Gimm T."/>
<person name="Wiese M."/>
<person name="Teschemacher B."/>
<person name="Deggerich A."/>
<person name="Schodel J."/>
<person name="Knaup K.X."/>
<person name="Hackenbeck T."/>
<person name="Hellerbrand C."/>
<person name="Amann K."/>
<person name="Wiesener M.S."/>
<person name="Honing S."/>
<person name="Eckardt K.U."/>
<person name="Warnecke C."/>
</authorList>
<dbReference type="PubMed" id="20624928"/>
<dbReference type="DOI" id="10.1096/fj.10-159806"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="38944" last="38950">
<title>Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha.</title>
<authorList>
<person name="Xu D."/>
<person name="Yao Y."/>
<person name="Lu L."/>
<person name="Costa M."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="20889502"/>
<dbReference type="DOI" id="10.1074/jbc.m110.160325"/>
</citation>
<scope>PHOSPHORYLATION AT SER-551; THR-555; SER-576; SER-589 AND SER-657</scope>
<scope>MUTAGENESIS OF SER-576 AND SER-657</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="2976" last="2986">
<title>Casein kinase 1 regulates human hypoxia-inducible factor HIF-1.</title>
<authorList>
<person name="Kalousi A."/>
<person name="Mylonis I."/>
<person name="Politou A.S."/>
<person name="Chachami G."/>
<person name="Paraskeva E."/>
<person name="Simos G."/>
</authorList>
<dbReference type="PubMed" id="20699359"/>
<dbReference type="DOI" id="10.1242/jcs.068122"/>
</citation>
<scope>PHOSPHORYLATION AT SER-247 BY CSNK1D/CK1</scope>
<scope>MUTAGENESIS OF SER-247</scope>
<scope>INTERACTION WITH ARNT</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="BMC Biol." volume="10" first="36" last="36">
<title>UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1alpha accumulation.</title>
<authorList>
<person name="Bandau S."/>
<person name="Knebel A."/>
<person name="Gage Z.O."/>
<person name="Wood N.T."/>
<person name="Alexandru G."/>
</authorList>
<dbReference type="PubMed" id="22537386"/>
<dbReference type="DOI" id="10.1186/1741-7007-10-36"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2012" name="Endocr. Relat. Cancer" volume="19" first="13" last="27">
<title>RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.</title>
<authorList>
<person name="Shan B."/>
<person name="Gerez J."/>
<person name="Haedo M."/>
<person name="Fuertes M."/>
<person name="Theodoropoulou M."/>
<person name="Buchfelder M."/>
<person name="Losa M."/>
<person name="Stalla G.K."/>
<person name="Arzt E."/>
<person name="Renner U."/>
</authorList>
<dbReference type="PubMed" id="22009797"/>
<dbReference type="DOI" id="10.1530/erc-11-0211"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="1962" last="1969">
<title>Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1alpha (HIF-1alpha) during hypoxia.</title>
<authorList>
<person name="Altun M."/>
<person name="Zhao B."/>
<person name="Velasco K."/>
<person name="Liu H."/>
<person name="Hassink G."/>
<person name="Paschke J."/>
<person name="Pereira T."/>
<person name="Lindsten K."/>
</authorList>
<dbReference type="PubMed" id="22128162"/>
<dbReference type="DOI" id="10.1074/jbc.m111.305615"/>
</citation>
<scope>INTERACTION WITH USP19</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2012" name="Nat. Cell Biol." volume="14" first="201" last="208">
<title>The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.</title>
<authorList>
<person name="Foxler D.E."/>
<person name="Bridge K.S."/>
<person name="James V."/>
<person name="Webb T.M."/>
<person name="Mee M."/>
<person name="Wong S.C."/>
<person name="Feng Y."/>
<person name="Constantin-Teodosiu D."/>
<person name="Petursdottir T.E."/>
<person name="Bjornsson J."/>
<person name="Ingvarsson S."/>
<person name="Ratcliffe P.J."/>
<person name="Longmore G.D."/>
<person name="Sharp T.V."/>
</authorList>
<dbReference type="PubMed" id="22286099"/>
<dbReference type="DOI" id="10.1038/ncb2424"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E57795" last="E57795">
<title>In silico structural and functional characterization of the RSUME splice variants.</title>
<authorList>
<person name="Gerez J."/>
<person name="Fuertes M."/>
<person name="Tedesco L."/>
<person name="Silberstein S."/>
<person name="Sevlever G."/>
<person name="Paez-Pereda M."/>
<person name="Holsboer F."/>
<person name="Turjanski A.G."/>
<person name="Arzt E."/>
</authorList>
<dbReference type="PubMed" id="23469069"/>
<dbReference type="DOI" id="10.1371/journal.pone.0057795"/>
</citation>
<scope>INTERACTION WITH RWDD3</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Oncogene" volume="34" first="1354" last="1362">
<title>SIRT2 regulates tumour hypoxia response by promoting HIF-1alpha hydroxylation.</title>
<authorList>
<person name="Seo K.S."/>
<person name="Park J.H."/>
<person name="Heo J.Y."/>
<person name="Jing K."/>
<person name="Han J."/>
<person name="Min K.N."/>
<person name="Kim C."/>
<person name="Koh G.Y."/>
<person name="Lim K."/>
<person name="Kang G.Y."/>
<person name="Uee Lee J."/>
<person name="Yim Y.H."/>
<person name="Shong M."/>
<person name="Kwak T.H."/>
<person name="Kweon G.R."/>
</authorList>
<dbReference type="PubMed" id="24681946"/>
<dbReference type="DOI" id="10.1038/onc.2014.76"/>
</citation>
<scope>ACETYLATION AT LYS-709</scope>
<scope>DEACETYLATION AT LYS-709 BY SIRT2</scope>
<scope>HYDROXYLATION</scope>
<scope>INTERACTION WITH SIRT2 AND EGLN1</scope>
<scope>MUTAGENESIS OF PRO-402; PRO-564 AND LYS-709</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0141786" last="E0141786">
<title>Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants.</title>
<authorList>
<person name="Prince T.L."/>
<person name="Kijima T."/>
<person name="Tatokoro M."/>
<person name="Lee S."/>
<person name="Tsutsumi S."/>
<person name="Yim K."/>
<person name="Rivas C."/>
<person name="Alarcon S."/>
<person name="Schwartz H."/>
<person name="Khamit-Kush K."/>
<person name="Scroggins B.T."/>
<person name="Beebe K."/>
<person name="Trepel J.B."/>
<person name="Neckers L."/>
</authorList>
<dbReference type="PubMed" id="26517842"/>
<dbReference type="DOI" id="10.1371/journal.pone.0141786"/>
</citation>
<scope>INTERACTION WITH HSP90AA1 AND HSP90AB1</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0123725" last="E0123725">
<title>Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.</title>
<authorList>
<person name="Kumar P."/>
<person name="Gullberg U."/>
<person name="Olsson I."/>
<person name="Ajore R."/>
</authorList>
<dbReference type="PubMed" id="25974097"/>
<dbReference type="DOI" id="10.1371/journal.pone.0123725"/>
</citation>
<scope>HYDROXYLATION PRO-564</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH CBFA2T3 AND EGLN1</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2017" name="Elife" volume="6" first="E22693" last="E22693">
<title>The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1alpha prolyl hydroxylation by regulating cellular iron levels.</title>
<authorList>
<person name="Miles A.L."/>
<person name="Burr S.P."/>
<person name="Grice G.L."/>
<person name="Nathan J.A."/>
</authorList>
<dbReference type="PubMed" id="28296633"/>
<dbReference type="DOI" id="10.7554/elife.22693"/>
</citation>
<scope>REGULATION BY IRON ION</scope>
<scope>HYDROXYLATION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2000" name="J. Biomol. Struct. Dyn." volume="18" first="169" last="179">
<title>A model for the complex between the hypoxia-inducible factor-1 (HIF-1) and its consensus DNA sequence.</title>
<authorList>
<person name="Michel G."/>
<person name="Minet E."/>
<person name="Ernest I."/>
<person name="Roland I."/>
<person name="Durant F."/>
<person name="Remacle J."/>
<person name="Michiels C."/>
</authorList>
<dbReference type="PubMed" id="11089639"/>
<dbReference type="DOI" id="10.1080/07391102.2000.10506656"/>
</citation>
<scope>3D-STRUCTURE MODELING</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="1802" last="1806">
<title>Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.</title>
<authorList>
<person name="Elkins J.M."/>
<person name="Hewitson K.S."/>
<person name="McNeill L.A."/>
<person name="Seibel J.F."/>
<person name="Schlemminger I."/>
<person name="Pugh C.W."/>
<person name="Ratcliffe P.J."/>
<person name="Schofield C.J."/>
</authorList>
<dbReference type="PubMed" id="12446723"/>
<dbReference type="DOI" id="10.1074/jbc.c200644200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 775-826 IN COMPLEX WITH HIF1AN</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5367" last="5372">
<title>Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.</title>
<authorList>
<person name="Freedman S.J."/>
<person name="Sun Z.-Y.J."/>
<person name="Poy F."/>
<person name="Kung A.L."/>
<person name="Livingston D.M."/>
<person name="Wagner G."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="11959990"/>
<dbReference type="DOI" id="10.1073/pnas.082117899"/>
</citation>
<scope>STRUCTURE BY NMR OF 786-826 IN COMPLEX WITH 302-418 OF EP300</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5271" last="5276">
<title>Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.</title>
<authorList>
<person name="Dames S.A."/>
<person name="Martinez-Yamout M."/>
<person name="De Guzman R.N."/>
<person name="Dyson H.J."/>
<person name="Wright P.E."/>
</authorList>
<dbReference type="PubMed" id="11959977"/>
<dbReference type="DOI" id="10.1073/pnas.082121399"/>
</citation>
<scope>STRUCTURE BY NMR OF 776-826 IN COMPLEX WITH 345-439 OF CREBBP</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2002" name="Science" volume="296" first="1886" last="1889">
<title>Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling.</title>
<authorList>
<person name="Min J.-H."/>
<person name="Yang H."/>
<person name="Ivan M."/>
<person name="Gertler F."/>
<person name="Kaelin W.G. Jr."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="12004076"/>
<dbReference type="DOI" id="10.1126/science.1073440"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 556-575 IN COMPLEX WITH ELOB; ELOC AND 54-213 OF VHL</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2002" name="Nature" volume="417" first="975" last="978">
<title>Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.</title>
<authorList>
<person name="Hon W.-C."/>
<person name="Wilson M.I."/>
<person name="Harlos K."/>
<person name="Claridge T.D.W."/>
<person name="Schofield C.J."/>
<person name="Pugh C.W."/>
<person name="Maxwell P.H."/>
<person name="Ratcliffe P.J."/>
<person name="Stuart D.I."/>
<person name="Jones E.Y."/>
</authorList>
<dbReference type="PubMed" id="12050673"/>
<dbReference type="DOI" id="10.1038/nature00767"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 549-582 IN COMPLEX WITH 17-112 OF ELOB; ELOC AND 52-213 OF VHL</scope>
</reference>
<comment type="function">
<text evidence="9 18 20 33 36 38 40 44 45 48 59">Functions as a master transcriptional regulator of the adaptive response to hypoxia. Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300. Activity is enhanced by interaction with both, NCOA1 or NCOA2. Interaction with redox regulatory protein APEX seems to activate CTAD and potentiates activation by NCOA1 and CREBBP. Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia.</text>
</comment>
<comment type="subunit">
<text evidence="9 13 14 16 17 19 20 21 22 23 24 27 28 30 32 34 35 36 37 38 39 41 42 46 49 52 53 54 55 57 59">Interacts with the ARNT; forms a heterodimer that binds core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (PubMed:10944113, PubMed:20699359). Interacts with COPS5; the interaction increases the transcriptional activity of HIF1A through increased stability (By similarity). Interacts with EP300 (via TAZ-type 1 domains); the interaction is stimulated in response to hypoxia and inhibited by CITED2. Interacts with CREBBP (via TAZ-type 1 domains). Interacts with NCOA1, NCOA2, APEX and HSP90. Interacts (hydroxylated within the ODD domain) with VHLL (via beta domain); the interaction, leads to polyubiquitination and subsequent HIF1A proteasomal degradation. During hypoxia, sumoylated HIF1A also binds VHL; the interaction promotes the ubiquitination of HIF1A. Interacts with SENP1; the interaction desumoylates HIF1A resulting in stabilization and activation of transcription. Interacts (Via the ODD domain) with ARD1A; the interaction appears not to acetylate HIF1A nor have any affect on protein stability, during hypoxia. Interacts with RWDD3; the interaction enhances HIF1A sumoylation. Interacts with TSGA10 (By similarity). Interacts with HIF3A (By similarity). Interacts with RORA (via the DNA binding domain); the interaction enhances HIF1A transcription under hypoxia through increasing protein stability. Interaction with PSMA7 inhibits the transactivation activity of HIF1A under both normoxic and hypoxia-mimicking conditions. Interacts with USP20. Interacts with RACK1; promotes HIF1A ubiquitination and proteasome-mediated degradation. Interacts (via N-terminus) with USP19. Interacts with SIRT2. Interacts (deacetylated form) with EGLN1. Interacts with CBFA2T3. Interacts with HSP90AA1 and HSP90AB1 (PubMed:26517842).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-80809">
<id>P27540</id>
<label>ARNT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-10988877">
<id>Q9C0J9</id>
<label>BHLHE41</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-722425">
<id>O00257</id>
<label>CBX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-1245604">
<id>Q96CJ1</id>
<label>EAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-1174818">
<id>Q9GZT9</id>
<label>EGLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-726614">
<id>Q96KS0</id>
<label>EGLN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-1175354">
<id>Q9H6Z9</id>
<label>EGLN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-372412">
<id>P11474</id>
<label>ESRRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-712740">
<id>P09467</id>
<label>FBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-6664760">
<id>P23771</id>
<label>GATA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-745632">
<id>Q9NWT6</id>
<label>HIF1AN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-477430">
<id>Q92831</id>
<label>KAT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-714236">
<id>Q13330</id>
<label>MTA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-636374">
<id>P46531</id>
<label>NOTCH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-725454">
<id>Q13438</id>
<label>OS9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-473160">
<id>Q8N2W9</id>
<label>PIAS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-4304679">
<id>P14618-1</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-359310">
<id>P25789</id>
<label>PSMA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-851558">
<id>Q9UHD8-1</id>
<label>SEPTIN9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-347161">
<id>P84022</id>
<label>SMAD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-1993627">
<id>O94888</id>
<label>UBXN7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-1050865">
<id>P40818</id>
<label>USP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-301246">
<id>P40337</id>
<label>VHL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-6942961">
<id>P17861</id>
<label>XBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-6143801">
<id>Q99PV5</id>
<label>Bhlhe41</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-8030618">
<id>Q5RIX9</id>
<label>e2f7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-8030813">
<id>Q6S7F2</id>
<label>E2f7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-2312731">
<id>Q61539</id>
<label>Esrrb</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-4567146">
<id>Q8BIF2</id>
<label>Rbfox3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447269">
<id>Q16665</id>
</interactant>
<interactant intactId="EBI-4422078">
<id>P51450-2</id>
<label>Rorc</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="58">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="48 58">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Nucleus speckle</location>
</subcellularLocation>
<text evidence="9">Colocalizes with HIF3A in the nucleus and speckles (By similarity). Cytoplasmic in normoxia, nuclear translocation in response to hypoxia (PubMed:9822602).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q16665-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q16665-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047335 VSP_007738"/>
</isoform>
<isoform>
<id>Q16665-3</id>
<name>3</name>
<name>I.3</name>
<sequence type="described" ref="VSP_044942"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="48">Expressed in most tissues with highest levels in kidney and heart. Overexpressed in the majority of common human cancers and their metastases, due to the presence of intratumoral hypoxia and as a result of mutations in genes encoding oncoproteins and tumor suppressors. A higher level expression seen in pituitary tumors as compared to the pituitary gland.</text>
</comment>
<comment type="induction">
<text evidence="43 48 50">Under reduced oxygen tension. Induced also by various receptor-mediated factors such as growth factors, cytokines, and circulatory factors such as PDGF, EGF, FGF2, IGF2, TGFB1, HGF, TNF, IL1B/interleukin-1 beta, angiotensin-2 and thrombin. However, this induction is less intense than that stimulated by hypoxia. Repressed by HIPK2 and LIMD1.</text>
</comment>
<comment type="domain">
<text>Contains two independent C-terminal transactivation domains, NTAD and CTAD, which function synergistically. Their transcriptional activity is repressed by an intervening inhibitory domain (ID).</text>
</comment>
<comment type="PTM">
<text evidence="29 31">S-nitrosylation of Cys-800 may be responsible for increased recruitment of p300 coactivator necessary for transcriptional activity of HIF-1 complex.</text>
</comment>
<comment type="PTM">
<text evidence="46 47">Requires phosphorylation for DNA-binding. Phosphorylation at Ser-247 by CSNK1D/CK1 represses kinase activity and impairs ARNT binding. Phosphorylation by GSK3-beta and PLK3 promote degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="33 34 40 41">Sumoylated; with SUMO1 under hypoxia. Sumoylation is enhanced through interaction with RWDD3. Both sumoylation and desumoylation seem to be involved in the regulation of its stability during hypoxia. Sumoylation can promote either its stabilization or its VHL-dependent degradation by promoting hydroxyproline-independent HIF1A-VHL complex binding, thus leading to HIF1A ubiquitination and proteasomal degradation. Desumoylation by SENP1 increases its stability amd transcriptional activity. There is a disaccord between various publications on the effect of sumoylation and desumoylation on its stability and transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="28 53">Acetylation of Lys-532 by ARD1 increases interaction with VHL and stimulates subsequent proteasomal degradation (PubMed:12464182). Deacetylation of Lys-709 by SIRT2 increases its interaction with and hydroxylation by EGLN1 thereby inactivating HIF1A activity by inducing its proteasomal degradation (PubMed:24681946).</text>
</comment>
<comment type="PTM">
<text evidence="25 34 37 51 54">Polyubiquitinated; in normoxia, following hydroxylation and interaction with VHL. Lys-532 appears to be the principal site of ubiquitination. Clioquinol, the Cu/Zn-chelator, inhibits ubiquitination through preventing hydroxylation at Asn-803. Ubiquitinated by a CUL2-based E3 ligase.</text>
</comment>
<comment type="PTM">
<text evidence="18 20 25 26 34 54 56">In normoxia, is hydroxylated on Pro-402 and Pro-564 in the oxygen-dependent degradation domain (ODD) by EGLN1/PHD2 and EGLN2/PHD1 (PubMed:11292861, PubMed:11566883, PubMed:12351678, PubMed:15776016, PubMed:25974097). EGLN3/PHD3 has also been shown to hydroxylate Pro-564 (PubMed:11292861, PubMed:11566883, PubMed:12351678, PubMed:15776016, PubMed:25974097). The hydroxylated prolines promote interaction with VHL, initiating rapid ubiquitination and subsequent proteasomal degradation (PubMed:11292861, PubMed:11566883, PubMed:12351678, PubMed:15776016, PubMed:25974097). Deubiquitinated by USP20 (PubMed:11292861, PubMed:11566883, PubMed:12351678, PubMed:15776016, PubMed:25974097). Under hypoxia, proline hydroxylation is impaired and ubiquitination is attenuated, resulting in stabilization (PubMed:11292861, PubMed:11566883, PubMed:12351678, PubMed:15776016, PubMed:25974097). In normoxia, is hydroxylated on Asn-803 by HIF1AN, thus abrogating interaction with CREBBP and EP300 and preventing transcriptional activation (PubMed:12080085). This hydroxylation is inhibited by the Cu/Zn-chelator, Clioquinol (PubMed:12080085). Repressed by iron ion, via Fe(2+) prolyl hydroxylase (PHD) enzymes-mediated hydroxylation and subsequent proteasomal degradation (PubMed:28296633).</text>
</comment>
<comment type="PTM">
<text>The iron and 2-oxoglutarate dependent 3-hydroxylation of asparagine is (S) stereospecific within HIF CTAD domains.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="64">Up-regulated in peripheral T-lymphocytes after T-cell receptor stimulation. Highest expression in peripheral blood leukocytes and thymus.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Hypoxia_inducible_factor"/>
<text>Hypoxia inducible factor entry</text>
</comment>
<dbReference type="EMBL" id="U22431">
<property type="protein sequence ID" value="AAC50152.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U29165">
<property type="protein sequence ID" value="AAC51210.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050127">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050115">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050116">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050117">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050118">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050119">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050120">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050121">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050122">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050123">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050124">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050125">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050126">
<property type="protein sequence ID" value="AAC68568.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ790247">
<property type="protein sequence ID" value="ACN88547.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF207601">
<property type="protein sequence ID" value="AAF20139.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF207602">
<property type="protein sequence ID" value="AAF20140.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF208487">
<property type="protein sequence ID" value="AAF20149.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF304431">
<property type="protein sequence ID" value="AAG43026.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB073325">
<property type="protein sequence ID" value="BAB70608.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009776">
<property type="protein sequence ID" value="AAP88778.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137129">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012527">
<property type="protein sequence ID" value="AAH12527.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58324.1">
<molecule id="Q16665-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9753.1">
<molecule id="Q16665-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9754.1">
<molecule id="Q16665-2"/>
</dbReference>
<dbReference type="PIR" id="I38972">
<property type="entry name" value="I38972"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001230013.1">
<molecule id="Q16665-3"/>
<property type="nucleotide sequence ID" value="NM_001243084.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001521.1">
<molecule id="Q16665-1"/>
<property type="nucleotide sequence ID" value="NM_001530.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_851397.1">
<molecule id="Q16665-2"/>
<property type="nucleotide sequence ID" value="NM_181054.2"/>
</dbReference>
<dbReference type="PDB" id="1D7G">
<property type="method" value="Model"/>
<property type="chains" value="D=15-73"/>
</dbReference>
<dbReference type="PDB" id="1H2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="S=786-826"/>
</dbReference>
<dbReference type="PDB" id="1H2L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="S=786-826"/>
</dbReference>
<dbReference type="PDB" id="1H2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="S=775-826"/>
</dbReference>
<dbReference type="PDB" id="1L3E">
<property type="method" value="NMR"/>
<property type="chains" value="A=786-826"/>
</dbReference>
<dbReference type="PDB" id="1L8C">
<property type="method" value="NMR"/>
<property type="chains" value="B=776-826"/>
</dbReference>
<dbReference type="PDB" id="1LM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="H=556-575"/>
</dbReference>
<dbReference type="PDB" id="1LQB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="D=549-582"/>
</dbReference>
<dbReference type="PDB" id="2ILM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="S=786-826"/>
</dbReference>
<dbReference type="PDB" id="3HQR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="S=558-574"/>
</dbReference>
<dbReference type="PDB" id="3HQU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="S=558-574"/>
</dbReference>
<dbReference type="PDB" id="4AJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.73"/>
<property type="chains" value="H=559-577"/>
</dbReference>
<dbReference type="PDB" id="4H6J">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=238-348"/>
</dbReference>
<dbReference type="PDB" id="5JWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B=788-806"/>
</dbReference>
<dbReference type="PDB" id="5L9B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="C/D=556-574"/>
</dbReference>
<dbReference type="PDB" id="5L9V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="C/D=395-411"/>
</dbReference>
<dbReference type="PDB" id="5LA9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="C/D=395-411"/>
</dbReference>
<dbReference type="PDB" id="5LAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="C/D=395-411"/>
</dbReference>
<dbReference type="PDB" id="6GFX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="D=560-577"/>
</dbReference>
<dbReference type="PDB" id="6GMR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="H=560-577"/>
</dbReference>
<dbReference type="PDBsum" id="1D7G"/>
<dbReference type="PDBsum" id="1H2K"/>
<dbReference type="PDBsum" id="1H2L"/>
<dbReference type="PDBsum" id="1H2M"/>
<dbReference type="PDBsum" id="1L3E"/>
<dbReference type="PDBsum" id="1L8C"/>
<dbReference type="PDBsum" id="1LM8"/>
<dbReference type="PDBsum" id="1LQB"/>
<dbReference type="PDBsum" id="2ILM"/>
<dbReference type="PDBsum" id="3HQR"/>
<dbReference type="PDBsum" id="3HQU"/>
<dbReference type="PDBsum" id="4AJY"/>
<dbReference type="PDBsum" id="4H6J"/>
<dbReference type="PDBsum" id="5JWP"/>
<dbReference type="PDBsum" id="5L9B"/>
<dbReference type="PDBsum" id="5L9V"/>
<dbReference type="PDBsum" id="5LA9"/>
<dbReference type="PDBsum" id="5LAS"/>
<dbReference type="PDBsum" id="6GFX"/>
<dbReference type="PDBsum" id="6GMR"/>
<dbReference type="SMR" id="Q16665"/>
<dbReference type="BioGRID" id="109338">
<property type="interactions" value="396"/>
</dbReference>
<dbReference type="CORUM" id="Q16665"/>
<dbReference type="DIP" id="DIP-29722N"/>
<dbReference type="ELM" id="Q16665"/>
<dbReference type="IntAct" id="Q16665">
<property type="interactions" value="107"/>
</dbReference>
<dbReference type="MINT" id="Q16665"/>
<dbReference type="STRING" id="9606.ENSP00000437955"/>
<dbReference type="BindingDB" id="Q16665"/>
<dbReference type="ChEMBL" id="CHEMBL4261"/>
<dbReference type="DrugBank" id="DB02342">
<property type="generic name" value="2-Methoxyestradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01136">
<property type="generic name" value="Carvedilol"/>
</dbReference>
<dbReference type="DrugBank" id="DB05959">
<property type="generic name" value="ENMD-1198"/>
</dbReference>
<dbReference type="DrugBank" id="DB08687">
<property type="generic name" value="FG-2216"/>
</dbReference>
<dbReference type="DrugBank" id="DB01275">
<property type="generic name" value="Hydralazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06082">
<property type="generic name" value="PX-478"/>
</dbReference>
<dbReference type="DrugCentral" id="Q16665"/>
<dbReference type="iPTMnet" id="Q16665"/>
<dbReference type="PhosphoSitePlus" id="Q16665"/>
<dbReference type="BioMuta" id="HIF1A"/>
<dbReference type="DMDM" id="2498017"/>
<dbReference type="jPOST" id="Q16665"/>
<dbReference type="MassIVE" id="Q16665"/>
<dbReference type="MaxQB" id="Q16665"/>
<dbReference type="PaxDb" id="Q16665"/>
<dbReference type="PeptideAtlas" id="Q16665"/>
<dbReference type="PRIDE" id="Q16665"/>
<dbReference type="ProteomicsDB" id="61021">
<molecule id="Q16665-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61022">
<molecule id="Q16665-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="7584"/>
<dbReference type="ABCD" id="Q16665">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="84">
<property type="antibodies" value="2199 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3091"/>
<dbReference type="Ensembl" id="ENST00000323441">
<molecule id="Q16665-2"/>
<property type="protein sequence ID" value="ENSP00000323326"/>
<property type="gene ID" value="ENSG00000100644"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000337138">
<molecule id="Q16665-1"/>
<property type="protein sequence ID" value="ENSP00000338018"/>
<property type="gene ID" value="ENSG00000100644"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000539097">
<molecule id="Q16665-3"/>
<property type="protein sequence ID" value="ENSP00000437955"/>
<property type="gene ID" value="ENSG00000100644"/>
</dbReference>
<dbReference type="GeneID" id="3091"/>
<dbReference type="KEGG" id="hsa:3091"/>
<dbReference type="UCSC" id="uc001xfq.3">
<molecule id="Q16665-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3091"/>
<dbReference type="DisGeNET" id="3091"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000100644.16"/>
<dbReference type="GeneCards" id="HIF1A"/>
<dbReference type="HGNC" id="HGNC:4910">
<property type="gene designation" value="HIF1A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000100644">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="603348">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16665"/>
<dbReference type="OpenTargets" id="ENSG00000100644"/>
<dbReference type="PharmGKB" id="PA29283"/>
<dbReference type="eggNOG" id="KOG3558">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156774"/>
<dbReference type="InParanoid" id="Q16665"/>
<dbReference type="KO" id="K08268"/>
<dbReference type="OMA" id="PTQMQEP"/>
<dbReference type="OrthoDB" id="547545at2759"/>
<dbReference type="PhylomeDB" id="Q16665"/>
<dbReference type="TreeFam" id="TF317772"/>
<dbReference type="PathwayCommons" id="Q16665"/>
<dbReference type="Reactome" id="R-HSA-1234158">
<property type="pathway name" value="Regulation of gene expression by Hypoxia-inducible Factor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1234174">
<property type="pathway name" value="Cellular response to hypoxia"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1234176">
<property type="pathway name" value="Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122947">
<property type="pathway name" value="NOTCH1 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849473">
<property type="pathway name" value="PTK6 Expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8857538">
<property type="pathway name" value="PTK6 promotes HIF1A stabilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951664">
<property type="pathway name" value="Neddylation"/>
</dbReference>
<dbReference type="SignaLink" id="Q16665"/>
<dbReference type="SIGNOR" id="Q16665"/>
<dbReference type="BioGRID-ORCS" id="3091">
<property type="hits" value="6 hits in 904 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="HIF1A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q16665"/>
<dbReference type="GeneWiki" id="HIF1A"/>
<dbReference type="GenomeRNAi" id="3091"/>
<dbReference type="Pharos" id="Q16665">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q16665"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="RNAct" id="Q16665">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100644">
<property type="expression patterns" value="Expressed in visceral pleura and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q16665">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q16665">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:1904115">
<property type="term" value="C:axon cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031514">
<property type="term" value="C:motile cilium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051879">
<property type="term" value="F:Hsp90 protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019896">
<property type="term" value="P:axonal transport of mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001922">
<property type="term" value="P:B-1 B cell homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003208">
<property type="term" value="P:cardiac ventricle morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051216">
<property type="term" value="P:cartilage development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006879">
<property type="term" value="P:cellular iron ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021987">
<property type="term" value="P:cerebral cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032963">
<property type="term" value="P:collagen metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002248">
<property type="term" value="P:connective tissue replacement involved in inflammatory response wound healing"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048546">
<property type="term" value="P:digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071542">
<property type="term" value="P:dopaminergic neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051541">
<property type="term" value="P:elastin metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035162">
<property type="term" value="P:embryonic hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061030">
<property type="term" value="P:epithelial cell differentiation involved in mammary gland alveolus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001947">
<property type="term" value="P:heart looping"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042541">
<property type="term" value="P:hemoglobin biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097411">
<property type="term" value="P:hypoxia-inducible factor-1alpha signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060574">
<property type="term" value="P:intestinal epithelial cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061072">
<property type="term" value="P:iris morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006089">
<property type="term" value="P:lactate metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007595">
<property type="term" value="P:lactation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046716">
<property type="term" value="P:muscle cell cellular homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030502">
<property type="term" value="P:negative regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045926">
<property type="term" value="P:negative regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001054">
<property type="term" value="P:negative regulation of mesenchymal cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903377">
<property type="term" value="P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070244">
<property type="term" value="P:negative regulation of thymocyte apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032007">
<property type="term" value="P:negative regulation of TOR signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001755">
<property type="term" value="P:neural crest cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021502">
<property type="term" value="P:neural fold elevation formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003151">
<property type="term" value="P:outflow tract morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032364">
<property type="term" value="P:oxygen homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903599">
<property type="term" value="P:positive regulation of autophagy of mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043536">
<property type="term" value="P:positive regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070101">
<property type="term" value="P:positive regulation of chemokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010634">
<property type="term" value="P:positive regulation of epithelial cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045648">
<property type="term" value="P:positive regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045821">
<property type="term" value="P:positive regulation of glycolytic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046886">
<property type="term" value="P:positive regulation of hormone biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035774">
<property type="term" value="P:positive regulation of insulin secretion involved in cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002052">
<property type="term" value="P:positive regulation of neuroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051000">
<property type="term" value="P:positive regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010870">
<property type="term" value="P:positive regulation of receptor biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061419">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030949">
<property type="term" value="P:positive regulation of vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903715">
<property type="term" value="P:regulation of aerobic respiration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0061418">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043619">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032909">
<property type="term" value="P:regulation of transforming growth factor beta2 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010039">
<property type="term" value="P:response to iron ion"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014850">
<property type="term" value="P:response to muscle activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061298">
<property type="term" value="P:retina vasculature development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010573">
<property type="term" value="P:vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00130">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="DisProt" id="DP00262"/>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00085"/>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001321">
<property type="entry name" value="HIF-1_alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR014887">
<property type="entry name" value="HIF-1_TAD_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR021537">
<property type="entry name" value="HIF_alpha_subunit"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001610">
<property type="entry name" value="PAC"/>
</dbReference>
<dbReference type="InterPro" id="IPR000014">
<property type="entry name" value="PAS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035965">
<property type="entry name" value="PAS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013767">
<property type="entry name" value="PAS_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013655">
<property type="entry name" value="PAS_fold_3"/>
</dbReference>
<dbReference type="Pfam" id="PF11413">
<property type="entry name" value="HIF-1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08778">
<property type="entry name" value="HIF-1a_CTAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00989">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08447">
<property type="entry name" value="PAS_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01080">
<property type="entry name" value="HYPOXIAIF1A"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00086">
<property type="entry name" value="PAC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00091">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55785">
<property type="entry name" value="SSF55785"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00229">
<property type="entry name" value="sensory_box"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50112">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Hypoxia-inducible factor 1-alpha" id="PRO_0000127220">
<location>
<begin position="1"/>
<end position="826"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="12">
<location>
<begin position="17"/>
<end position="70"/>
</location>
</feature>
<feature type="domain" description="PAS 1" evidence="11">
<location>
<begin position="85"/>
<end position="158"/>
</location>
</feature>
<feature type="domain" description="PAS 2" evidence="11">
<location>
<begin position="228"/>
<end position="298"/>
</location>
</feature>
<feature type="domain" description="PAC">
<location>
<begin position="302"/>
<end position="345"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TSGA10" evidence="8">
<location>
<begin position="1"/>
<end position="401"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding" evidence="9">
<location>
<begin position="21"/>
<end position="30"/>
</location>
</feature>
<feature type="region of interest" description="Required for heterodimer formation with ARNT" evidence="9">
<location>
<begin position="170"/>
<end position="191"/>
</location>
</feature>
<feature type="region of interest" description="N-terminal VHL recognition site">
<location>
<begin position="380"/>
<end position="417"/>
</location>
</feature>
<feature type="region of interest" description="ODD">
<location>
<begin position="401"/>
<end position="603"/>
</location>
</feature>
<feature type="region of interest" description="NTAD">
<location>
<begin position="531"/>
<end position="575"/>
</location>
</feature>
<feature type="region of interest" description="C-terminal VHL recognition site">
<location>
<begin position="556"/>
<end position="572"/>
</location>
</feature>
<feature type="region of interest" description="ID">
<location>
<begin position="576"/>
<end position="785"/>
</location>
</feature>
<feature type="region of interest" description="CTAD">
<location>
<begin position="786"/>
<end position="826"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="10">
<location>
<begin position="718"/>
<end position="721"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Thr">
<location>
<begin position="615"/>
<end position="621"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1" evidence="46">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="4-hydroxyproline" evidence="20">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="53">
<location>
<position position="532"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="47">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3-beta" evidence="47">
<location>
<position position="555"/>
</location>
</feature>
<feature type="modified residue" description="4-hydroxyproline" evidence="18 20 26 54">
<location>
<position position="564"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="47">
<location>
<position position="576"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="47">
<location>
<position position="589"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="47">
<location>
<position position="657"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="53">
<location>
<position position="709"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="65">
<location>
<position position="800"/>
</location>
</feature>
<feature type="modified residue" description="(3S)-3-hydroxyasparagine" evidence="25">
<location>
<position position="803"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="33 40">
<location>
<position position="391"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="33 40">
<location>
<position position="477"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="66">
<location>
<position position="532"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="66">
<location>
<position position="538"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="66">
<location>
<position position="547"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_044942" evidence="60">
<original>MEGAGGANDKKK</original>
<variation>MSSQCRSLENKFVFLKEGLGNSKPEELEEIRIENGR</variation>
<location>
<begin position="1"/>
<end position="12"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047335" evidence="63">
<original>G</original>
<variation>I</variation>
<location>
<position position="735"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_007738" evidence="63">
<location>
<begin position="736"/>
<end position="826"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11549465." id="VAR_049541">
<original>P</original>
<variation>S</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11549467." id="VAR_049542">
<original>A</original>
<variation>T</variation>
<location>
<position position="588"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1802821." id="VAR_015854">
<original>T</original>
<variation>A</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity." evidence="46">
<original>S</original>
<variation>A</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired kinase activity." evidence="46">
<original>S</original>
<variation>D</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in HIF1A protein turnover rate but increased transcriptional activity; when associated with R-391; R-477 and R-532." evidence="40">
<original>K</original>
<variation>R</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes 1 sumoylation. Abolishes 1 sumoylation; when associated with R-532. Abolishes 2 sumoylations; when associated with R-477. No change in HIF1A protein turnover rate but increased transcriptional activity; when associated with R-377; R-477 and R-532." evidence="33 40">
<original>K</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in VHLE3-dependent ubiquitination." evidence="20">
<original>P</original>
<variation>A</variation>
<location>
<position position="394"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes VHLE3-dependent ubiquitination; when associated with A-400." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes VHLE3-dependent ubiquitination; when associated with A-397." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes in VHLE3-dependent ubiquitination, abolishes oxygen-dependent regulation of VP16, partially reduced VHLE target site ubiquitination and no interaction with VHL. No VHLE target site ubiquitination; when associated with G-564. Increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation; when associated with A-564." evidence="20 37 53">
<original>P</original>
<variation>A</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation nor in ARD1-mediated acetylation." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes 1 sumoylation. Abolishes 2 sumoylations; when associated with R-391. No change in HIF1A protein turnover rate but increased transcriptional activity; when associated with R-377; R-391 and R-532." evidence="33 40">
<original>K</original>
<variation>R</variation>
<location>
<position position="477"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced ubiquitination. No change in sumoylation nor on interaction with ARD1A. No change in HIF1A protein turnover rate but increased transcriptional activity; when associated with R-377; R-391 and R-477. Complete loss of ubiquitination, but no change in VHL binding; when associated with K-538 and K-547." evidence="16 33 35 37 40">
<original>K</original>
<variation>R</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation, but reduced ubiquitination. Complete loss of ubiquitination, but no change in VHL binding; when associated with K-532 and K-547." evidence="16 33 37">
<original>K</original>
<variation>R</variation>
<location>
<position position="538"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in sumoylation, but reduced ubiquitination. Complete loss of ubiquitination, but no change in VHL binding; when associated with K-532 and K-538." evidence="16 33 37">
<original>K</original>
<variation>R</variation>
<location>
<position position="547"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive expression under nonhypoxic conditions by decreasing ubiquitination." evidence="15">
<original>S</original>
<variation>G</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive expression under nonhypoxic conditions by decreasing ubiquitination." evidence="15">
<original>T</original>
<variation>A</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation; when associated with A-402." evidence="20 37 53">
<original>P</original>
<variation>A</variation>
<location>
<position position="564"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in VHL-dependent ubiquitination. Partially reduced VHLE target site ubiquitination. No VHLE target site ubiquitination; when associated with A-402." evidence="20 37 53">
<original>P</original>
<variation>G</variation>
<location>
<position position="564"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces stabilization of the protein." evidence="47">
<original>S</original>
<variation>A</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces stabilization of the protein." evidence="47">
<original>S</original>
<variation>A</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes SIRT2-mediated deacetylation, increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation. Increases interaction with EGLN1." evidence="53">
<original>K</original>
<variation>R</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="mutagenesis site" description="Dramatic reduction of accumulation in the nucleus in response to hypoxia." evidence="16 58">
<original>K</original>
<variation>T</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with EP300 and transactivation activity." evidence="30">
<original>L</original>
<variation>A</variation>
<location>
<position position="795"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks increase in transcriptional activation caused by nitrosylation." evidence="13 31">
<original>C</original>
<variation>A</variation>
<location>
<position position="800"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes hypoxia-inducible transcriptional activation of ctaD." evidence="13 31">
<original>C</original>
<variation>S</variation>
<location>
<position position="800"/>
</location>
</feature>
<feature type="mutagenesis site" description="Recruits CREBBP. No enhancement of CREBBP by Clioquinol in the presence of FIH1. No change in nuclear location nor on repression of transcriptional activity in the presence of histone deacetylase inhibitor." evidence="36 38">
<original>N</original>
<variation>A</variation>
<location>
<position position="803"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC68568." ref="3" evidence="64">
<original>F</original>
<variation>L</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="241"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="251"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="258"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="284"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="298"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="305"/>
<end position="308"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="310"/>
<end position="325"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="327"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="332"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="408"/>
<end position="410"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="559"/>
<end position="562"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="779"/>
<end position="783"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="784"/>
<end position="787"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="789"/>
<end position="792"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="797"/>
<end position="803"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="807"/>
<end position="809"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="815"/>
<end position="822"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1H2K"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1L3E"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1L8C"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4H6J"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5L9B"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5L9V"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LA9"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61221"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00140"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10202154"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10594042"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10758161"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10944113"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11006129"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11292861"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389899"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11566883"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11959977"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11959990"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12004076"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12050673"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12080085"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12351678"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446723"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12464182"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12560087"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12778114"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12914934"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14757845"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15465032"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15776016"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16288748"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16543236"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16862177"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16973622"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17244529"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17610843"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17956732"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18658046"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19046997"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19528298"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20624928"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20699359"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20889502"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22009797"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22128162"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22286099"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22537386"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23469069"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24681946"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25974097"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26517842"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28296633"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8917528"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9822602"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9887100"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18638657"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7539918"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9079689"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="64" type="ECO:0000305"/>
<evidence key="65" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12914934"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16862177"/>
</source>
</evidence>
<sequence length="826" mass="92670" checksum="ABD4F7DAA135BE2D" modified="1996-11-01" version="1">MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNVSSHLDKASVMRLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFVMVLTDDGDMIYISDNVNKYMGLTQFELTGHSVFDFTHPCDHEEMREMLTHRNGLVKKGKEQNTQRSFFLRMKCTLTSRGRTMNIKSATWKVLHCTGHIHVYDTNSNQPQCGYKKPPMTCLVLICEPIPHPSNIEIPLDSKTFLSRHSLDMKFSYCDERITELMGYEPEELLGRSIYEYYHALDSDHLTKTHHDMFTKGQVTTGQYRMLAKRGGYVWVETQATVIYNTKNSQPQCIVCVNYVVSGIIQHDLIFSLQQTECVLKPVESSDMKMTQLFTKVESEDTSSLFDKLKKEPDALTLLAPAAGDTIISLDFGSNDTETDDQQLEEVPLYNDVMLPSPNEKLQNINLAMSPLPTAETPKPLRSSADPALNQEVALKLEPNPESLELSFTMPQIQDQTPSPSDGSTRQSSPEPNSPSEYCFYVDSDMVNEFKLELVEKLFAEDTEAKNPFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSPLESSSASPESASPQSTVTVFQQTQIQEPTANATTTTATTDELKTVTKDRMEDIKILIASPSPTHIHKETTSATSSPYRDTQSRTASPNRAGKGVIEQTEKSHPRSPNVLSVALSQRTTVPEEELNPKILALQNAQRKRKMEHDGSLFQAVGIGTLLQQPDDHAATTSLSWKRVKGCKSSEQNGMEQKTIILIPSDLACRLLGQSMDESGLPQLTSYDCEVNAPIQGSRNLLQGEELLRALDQVN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

